What question did this study set out to answer?

To summarize the progress and recommendations regarding the use of Haemophilus influenzae type b polysaccharide vaccine in children.

March 22, 2026PEDIATRICS

Progress in Haemophilus Type b Polysaccharide Vaccine Use in the United States

View Full Paper

Ask AI

Bookmark

Authors

Survey reports on the adoption of Haemophilus influenzae type b vaccine in children, indicating widespread usage and endorsements.

To summarize the progress and recommendations regarding the use of Haemophilus influenzae type b polysaccharide vaccine in children.
Licensing of the vaccine by the FDA in 1985.
Recommendations for routine use by health committees published shortly thereafter.
Distribution data of the vaccine assessed from licensure to July 1986.
Over 5 million doses of the vaccine were distributed in the United States by July 1986.
Routine usage was recommended for children starting at 24 months of age.

Cochi et al. (1988) studied this question.

View Full Paper

Ask AI

Bookmark